Detection of De Novo Dividing Stem Cells In Situ through Double Nucleotide Analogue Labeling

Sheed Itaman, Grigori Enikolopov, Oleg V. PodgornyCells 2022 · DOI

TL;DR

This paper introduces a novel "double labeling" technique to precisely identify and track stem cells that are newly entering the cell cycle after a period of dormancy (quiescence). This method overcomes limitations of previous approaches and was successfully used to demonstrate that memantine, a drug for Alzheimer's, stimulates quiescent neural stem cells in the adult brain to divide.

What Problem Does This Paper Address?

Somatic stem cells are crucial for tissue repair and regeneration, but they often exist in a dormant state called quiescence. Understanding when and why these quiescent cells "wake up" and start dividing is vital for fields ranging from regenerative medicine to aging research. However, directly observing these "de novo" divisions in living tissue has been technically challenging. Existing methods, like tracking cells that retain a label over time (label-retaining cells or LRCs), are retrospective and can't pinpoint the exact moment a quiescent cell re-enters the cell cycle. Similarly, methods relying on fluorescent protein decay are also indirect. The authors aim to fill this gap by developing a method that specifically identifies cells that have just exited quiescence and are entering their first cell cycle division.

Methods

The core of this paper is a novel double nucleotide analogue labeling scheme. Here's how it works:

  1. Cumulative Labeling (BrdU): Mice are continuously infused with a thymidine analogue, 5-bromo-2'-deoxyuridine (BrdU), for an extended period (7 days). This labels all cells that pass through the S phase (DNA replication) during this time. Cells that divide frequently will have their BrdU label diluted to near undetectable levels over time.
  2. Pulse Labeling (EdU): After the cumulative labeling period, the BrdU infusion is stopped. A short "chase" period (14 hours) follows, which is longer than the S phase duration but shorter than a full cell cycle. Then, a second thymidine analogue, 5-ethynyl-2'-deoxyuridine (EdU), is administered as a single pulse. This labels only cells that are in their S phase during that specific pulse.
  3. Discrimination:
    • Cells labeled with both BrdU and EdU are those that have divided multiple times during the 7-day BrdU period and are now dividing again.
  4. Cells labeled with only EdU (EdU+BrdU-) are the key focus. These cells were quiescent during the 7-day BrdU period, entered the cell cycle during the chase period, and were in S phase when EdU was administered. This signifies a "de novo" division event.

The researchers used Nestin-GFP reporter mice to identify neural stem cells (radial glia-like cells, RGLs) and combined the nucleotide labeling with immunofluorescence for markers like GFAP to determine the phenotype of these newly dividing cells.

Datasets

Not discussed in the paper. The study uses adult male Nestin-GFP transgenic mice as the experimental model.

Key Insights and Ideas

  • Precise "De Novo" Division Detection: The double labeling strategy is a significant advancement, allowing researchers to pinpoint cells that have just exited quiescence and entered their first cell cycle division, rather than just identifying cells that have divided infrequently over a long period.
  • Quiescent RGLs are the Primary Source of New Divisions: In the adult hippocampus, the majority of cells identified as "de novo" dividing (EdU+BrdU-) were characterized as radial glia-like stem cells (RGLs), supporting the model that these are the primary quiescent stem cells that initiate neurogenesis.
  • Memantine's Mechanism of Action: The study provides direct evidence that memantine, an Alzheimer's drug, enhances adult hippocampal neurogenesis by increasing the recruitment of quiescent RGLs into the cell cycle. This is a crucial mechanistic insight into how the drug might exert its therapeutic effects.

Key Results

  • The double labeling method successfully identified a population of EdU+BrdU- cells, representing de novo dividing cells.
  • In control mice, approximately 12% of EdU+ cells were EdU+BrdU-, and over 50% of these de novo dividing cells exhibited the bona fide RGL phenotype (GFP+GFAP+process+).
  • Treatment with memantine significantly increased the total number of EdU+ cells (proliferation) and, importantly, the number of de novo dividing cells (EdU+BrdU-).
  • Specifically, memantine treatment led to a 4.1-fold increase in de novo dividing RGLs (GFP+GFAP+process+) compared to controls.

Limitations and Future Work

  • Potential Cytotoxicity: The authors acknowledge that thymidine analogues like BrdU and EdU can have cytotoxic effects. However, they argue that their experimental design minimizes this risk: BrdU is delivered at a relatively low dose, and the focus is on cells lacking the BrdU label (EdU+BrdU-). They also note that the short chase period after EdU administration is unlikely to cause significant toxicity. For future studies involving longer chase periods, they suggest using less toxic analogues like F-ara-EdU.
  • Generalizability: While validated in the adult hippocampus, the authors suggest the method is universally applicable to other stem cell niches (including cancerous ones) in developing and adult tissues.
  • Long-Term Fate Tracing: The paper highlights that extending the chase period after the second label pulse could allow for tracing the fates of progeny originating from these newly activated stem cells, offering deeper insights into tissue renewal and repair.
  • Impact of Aging and Pathology: The method is well-suited for assessing how aging, disease, or drug treatments affect the balance between stem cell quiescence and division, opening avenues for future research in these areas.

Summary updated

Abstract

Tissue-specific somatic stem cells are characterized by their ability to reside in a state of prolonged reversible cell cycle arrest, referred to as quiescence. Maintenance of a balance between cell quiescence and division is critical for tissue homeostasis at the cellular level and is dynamically regulated by numerous extrinsic and intrinsic factors. Analysis of the activation of quiescent stem cells has been challenging because of a lack of methods for direct detection of de novo dividing cells. Here, we present and experimentally verify a novel method based on double labeling with thymidine analogues to detect de novo dividing stem cells in situ. In a proof of concept for the method, we show that memantine, a drug widely used for Alzheimer's disease therapy and a known strong inducer of adult hippocampal neurogenesis, increases the recruitment into the division cycle of quiescent radial glia-like stem cells-primary precursors of the adult-born neurons in the hippocampus. Our method could be applied to assess the effects of aging, pathology, or drug treatments on the quiescent stem cells in stem cell compartments in developing and adult tissues.
BibTeX
@inproceedings{itaman2022detection,
  author = {Sheed Itaman and Grigori Enikolopov and Oleg V. Podgorny},
  title = {{Detection of De Novo Dividing Stem Cells In Situ through Double Nucleotide Analogue Labeling}},
  booktitle = {Cells},
  year = {2022},
  doi = {10.3390/cells11244001},
}
Figure